BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:1974@azbio.org
DTSTART;TZID=America/Phoenix:20251013T173000
DTEND;TZID=America/Phoenix:20251013T193000
DTSTAMP:20250930T030658Z
URL:https://www.azbio.org/events/leading-women-biotech-and-beyond-5
SUMMARY:Leading Women: Biotech and Beyond - 850 PBC - 13 Oct 25 17:30
DESCRIPTION:\nJoin us to kick off Arizona Bioscience Week in style!\nLeadin
 g Women: Biotech and Beyond\n\nJoin us for cocktails connections and stimu
 lating conversation with some of biotech’s leading women.&nbsp\; &nbsp\;
  &nbsp\;\n\nDate:&nbsp\; Monday\, October 13\, 2025\n\nTime:&nbsp\;&nbsp\;
 5:30PM – 7:30 PM\n\nLocation:&nbsp\;850 PBC&nbsp\;\n\n850 N 5th Street\,
  Phoenix\, Arizona 85004\nAgenda:&nbsp\;&nbsp\;\n5:30 – Cocktails\n\n6:3
 0 – Leading Women Panel&nbsp\;\n\n7:30&nbsp\; – Event Concludes&nbsp\;
 \nTickets\nRegistration is complimentary for AZBio Members\, Elected Leade
 rs\, and credentialed Media.\n\nNon Members:&nbsp\; $50\n\nTo check if you
 r company is an AZBio Member\,&nbsp\;click here.\nRegister\nRegister Early
  - This event fills up fast!\nSpeakers\n\n\nSarah “Holly” Hollingswort
 h Lisanby\, MD\, DLFAPA\nFounding Dean and Foundation Professor with Tenur
 e\nSchool of Medicine and Advanced Medical Engineering\nArizona State Univ
 ersity\n\nSarah Hollingsworth&nbsp\;“Holly”&nbsp\;Lisanby\, MD\, DLFAP
 A\, an internationally renowned innovator of neuromodulation technologies\
 , has a track record of visionary senior leadership in academic medicine a
 nd federal government.&nbsp\; She is the Founding Dean and Foundation Prof
 essor of the Arizona State University (ASU) School of Medicine and Advance
 d Medical Engineering and Professor Emeritus at the Duke University Depart
 ment of Psychiatry and Behavioral Sciences.&nbsp\; Prior to her current ro
 le at ASU\, Dr. Lisanby served as the Founding Director of the National In
 stitute of Mental Health (NIMH)&nbsp\;Division of Translational Research w
 hich funds a portfolio of research directed towards the discovery of preve
 ntions\, treatments\, and cures for mental illness across the lifespan.&nb
 sp\; &nbsp\;Learn More\n\n&nbsp\;\n\nNoreen Scheu\, MBA (Panel Moderator)\
 n\nWith 25 years in pharmaceuticals and combination products\, this mentor
  has expertise in corporate strategy\, competitive intelligence\, and mark
 et analysis. Their experience includes roles at Upsher-Smith Laboratories\
 , LLC\, and supporting gene therapy startups. A dedicated advocate for Ari
 zona’s startup ecosystem\, they volunteer with Tech Launch Arizona and V
 enture Café Phoenix.\n\n&nbsp\;\n\n&nbsp\;\n\n\n\nSowmya Arunkumar\nSVP\,
  Regulatory Affairs and Quality Assurance\nCND Life Sciences\, Inc.&nbsp\;
 \n\nSowmya Arunkumar joined CND Life Sciences as SVP\, Regulatory Affairs 
 and Quality Assurance in early 2025\, bringing over 20 years of experience
  in diagnostics\, medical devices\, and digital health. Prior to this role
 \, she served as Vice President at Tandem Diabetes Inc. in San Diego and s
 pent 17 years at Cepheid\, a Danaher company\, where she built a global re
 gulatory team and played a key role in registering diagnostic products wor
 ldwide. Sowmya has a proven track record of securing global approvals and 
 developing compliant quality and regulatory strategies to expedite time to
  market. She holds a Master’s degree in Microbiology and has completed t
 he Executive Development Program at the Kellogg School of Management. Sowm
 ya Arunkumar is passionate about team building and organizational structur
 e\, striving to help businesses achieve their full potential.\n\n Mia Chor
 ney\, DNP\, FNPBC\, MSCP\n\nDr. Mia Chorney is a distinguished leader in t
 he field of Genetics\, Cardiology &amp\; Women’s Hormone Health\, blendi
 ng thirty years of comprehensive healthcare experience with an impressive 
 depth of knowledge in cardiovascular care\, genetics\, menopause\, functio
 nal medicine and artificial intelligence (AI)\; further\, leading to a pas
 sion for precision medicine and women's health. Her strategic vision and p
 roblem-solving acumen have crystallized in her role as Co-founder\, &amp\;
  Chief Medical Officer of The Pause™ Technologies\, where she spearheads
  innovations in AI to tackle the challenges of perimenopause and menopause
 \, and as a driving force behind equity and data in Women's Health.&nbsp\;
 \n\n\nMelissa M. Herbst-Kralovetz\, PhD\nProfessor\nDirector\, Women’s H
 ealth Research Program\nDepartment of Basic Medical Sciences\nDepartment o
 f Obstetrics and Gynecology\nThe University of Arizona College of Medicine
 -Phoenix\n&nbsp\;\nDr.&nbsp\; Melissa M. Herbst-Kralovetz is the 2025 Ariz
 ona Bioscience Researcher of the Year.&nbsp\;Dr. Herbst-Kralovetz\, direct
 or of the Women’s Health Microbiome Initiative at the College of Medicin
 e – Phoenix\, has a long-standing interest in women’s health. Her lab 
 is focused on understanding the microbiome and host-microbe interactions i
 n the female reproductive tract as it relates to gynecologic and oncologic
  health outcomes. Additionally\, she works to provide diagnostics for wome
 n in underserved populations\, including through the Native American Cance
 r Prevention Program.She has been funded by the National Institutes of Hea
 lth and foundations\, including the Flinn Foundation\, the Alternatives Re
 search and Development Foundation and most recently the Mary Kay Foundatio
 n\, to study cervical and endometrial cancer. Herbst-Kralovetz utilizes cl
 inical and preclinical models and an innovative 3-D bioreactor system to s
 tudy human epithelial and innate immune responses to pathogens. In additio
 n\, she has recently moved into other -omics technologies\, including immu
 noproteomics and metabolomics.\n\nDr. Herbst-Kralovetz has a long-standing
  interest in enhancing women’s health outcomes through translational res
 earch and is creating an at-home gynecologic testing system for early dete
 ction of gynecologic conditions such as endometrial cancer\, endometriosis
  and adenomyosis. The test pairs non-invasive sampling techniques with adv
 anced biomarker analysis developed through Herbst-Kralovetz’s research.\
 n\n&nbsp\;\n\nSponsorships are available.&nbsp\; For more information\,&nb
 sp\;contact AZBio.\nThank You Sponsors!\n\n\n&nbsp\;\n\n&nbsp\;\n\n&nbsp\;
 \n\n&nbsp\;\n\n&nbsp\; &nbsp\;\n\n&nbsp\;\n\n&nbsp\;\n\n&nbsp\;\n\n\n\n
CATEGORIES:AZ - Central
LOCATION:850 PBC\, 850 N 5th Street\, Phoenix\, AZ\, 85004\, United States
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=850 N 5th Street\, Phoenix\
 , AZ\, 85004\, United States;X-APPLE-RADIUS=100;X-TITLE=850 PBC:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20241013T173000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR